NEW: Sun Pharma is a leading exporter of medications to the U.S., despite multiple manufacturing breaches.
“The FDA turns a blind eye. If your market [share] is big enough, then you get leeway,” one former inspector said.
A Giant Indian Drugmaker Failed to Fix Safety Breaches. The FDA Let It Off the Hook Again and Again.
Documents obtained by ProPublica offer a rare glimpse into discussions between the global drugmaker Sun Pharma and the FDA, exposing how the agency tolerated substandard manufacturing for years.